Lord, Abbett & Co
BLU

Lord, Abbett & Co’s BELLUS Health Inc. BLU Stock Holding History

Lord, Abbett & Co’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-838,269
Closed -$6.04M – 600
2023
Q1 		$6.04M Sell
838,269
-401,220
-32% -$3.11M 0.02% 455
2022
Q4 		$10.2M Sell
1,239,489
-22,623
-2% -$211K 0.04% 423
2022
Q3 		$13.3M Sell
1,262,112
-63,264
-5% -$672K 0.05% 370
2022
Q2 		$12.2M Buy
1,325,376
+163,518
+14% +$1.34M 0.04% 379
2022
Q1 		$7.99M Sell
1,161,858
-24,702
-2% -$159K 0.02% 492
2021
Q4 		$9.55M Buy
+1,186,560
New +$7.87M 0.02% 498

Other funds holding BLU

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.32B AUM 51.82% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Lord, Abbett & Co's BLU Position: Q2 2023 in Review

Lord, Abbett & Co sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 838,269 shares — an estimated $6.04M sold.

Lord, Abbett & Co first reported a position in BLU in Q4 2021 and held it in 6 quarters. The position peaked at $13.3M in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Lord, Abbett & Co reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Lord, Abbett & Co sold 838,269 BELLUS Health Inc. shares in Q2 2023, an estimated $6.04M.
  • Lord, Abbett & Co first reported a position in BELLUS Health Inc. in Q4 2021 and held it in 6 quarters.
  • Lord, Abbett & Co's BELLUS Health Inc. position peaked at $13.3M in Q3 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Lord, Abbett & Co's 13F filing for Q2 2023, filed 14 Aug 2023.